APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostacyclin Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prostacyclin Drug Market Analysis and Forecast 2026-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchProstacyclin Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostacyclin Drug Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Prostacyclin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostacyclin Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostacyclin Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Prostacyclin Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prostacyclin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prostacyclin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prostacyclin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prostacyclin Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prostacyclin Drug include Teva, GSK, Bayer AG, United Therapeutics, Toray, Tide Pharma and Actelion (J & J), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prostacyclin Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prostacyclin Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Prostacyclin Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostacyclin Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prostacyclin Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prostacyclin Drug sales, projected growth trends, production technology, application and end-user industry.

Prostacyclin Drug Segment by Company

Teva

GSK

Bayer AG

United Therapeutics

Toray

Tide Pharma

Actelion (J & J)

Prostacyclin Drug Segment by Type

Beraprost Sodium

Epoprostenol Sodium

Treprostinil

Iloprost

Prostacyclin Drug Segment by Application

For Injection

For Inhalation

For Oral

Prostacyclin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prostacyclin Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prostacyclin Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostacyclin Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostacyclin Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Beraprost Sodium Major Manufacturers Table 3. Epoprostenol Sodium Major Manufacturers Table 4. Treprostinil Major Manufacturers Table 5. Iloprost Major Manufacturers Table 6. Global Prostacyclin Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. For Injection Major Manufacturers Table 8. For Inhalation Major Manufacturers Table 9. For Oral Major Manufacturers Table 10. Prostacyclin Drug Industry Trends Table 11. Prostacyclin Drug Industry Drivers Table 12. Prostacyclin Drug Industry Opportunities and Challenges Table 13. Prostacyclin Drug Industry Restraints Table 14. Global Prostacyclin Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Prostacyclin Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Prostacyclin Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Prostacyclin Drug Revenue Market Share by Region (2021-2026) Table 18. Global Prostacyclin Drug Revenue Market Share by Region (2027-2032) Table 19. Global Prostacyclin Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Prostacyclin Drug Sales by Region (2021-2026) & (K Units) Table 21. Global Prostacyclin Drug Sales by Region (2027-2032) & (K Units) Table 22. Global Prostacyclin Drug Sales Market Share by Region (2021-2026) Table 23. Global Prostacyclin Drug Sales Market Share by Region (2027-2032) Table 24. Global Prostacyclin Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prostacyclin Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Prostacyclin Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Prostacyclin Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Prostacyclin Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Prostacyclin Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Prostacyclin Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Prostacyclin Drug Manufacturers, Product Type & Application Table 32. Global Prostacyclin Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Prostacyclin Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Prostacyclin Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Prostacyclin Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Prostacyclin Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Prostacyclin Drug Revenue Market Share by Type (2021-2026) Table 39. Global Prostacyclin Drug Revenue Market Share by Type (2027-2032) Table 40. Global Prostacyclin Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 42. Global Prostacyclin Drug Sales by Type (2027-2032) & (K Units) Table 43. Global Prostacyclin Drug Sales Market Share by Type (2021-2026) Table 44. Global Prostacyclin Drug Sales Market Share by Type (2027-2032) Table 45. Global Prostacyclin Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global Prostacyclin Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global Prostacyclin Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prostacyclin Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Prostacyclin Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Prostacyclin Drug Revenue Market Share by Application (2021-2026) Table 51. Global Prostacyclin Drug Revenue Market Share by Application (2027-2032) Table 52. Global Prostacyclin Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Prostacyclin Drug Sales by Application (2027-2032) & (K Units) Table 55. Global Prostacyclin Drug Sales Market Share by Application (2021-2026) Table 56. Global Prostacyclin Drug Sales Market Share by Application (2027-2032) Table 57. Global Prostacyclin Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Prostacyclin Drug Price by Application (2027-2032) & (US$/Unit) Table 59. Teva Company Information Table 60. Teva Business Overview Table 61. Teva Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Teva Prostacyclin Drug Product Portfolio Table 63. Teva Recent Development Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GSK Prostacyclin Drug Product Portfolio Table 68. GSK Recent Development Table 69. Bayer AG Company Information Table 70. Bayer AG Business Overview Table 71. Bayer AG Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bayer AG Prostacyclin Drug Product Portfolio Table 73. Bayer AG Recent Development Table 74. United Therapeutics Company Information Table 75. United Therapeutics Business Overview Table 76. United Therapeutics Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. United Therapeutics Prostacyclin Drug Product Portfolio Table 78. United Therapeutics Recent Development Table 79. Toray Company Information Table 80. Toray Business Overview Table 81. Toray Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Toray Prostacyclin Drug Product Portfolio Table 83. Toray Recent Development Table 84. Tide Pharma Company Information Table 85. Tide Pharma Business Overview Table 86. Tide Pharma Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Tide Pharma Prostacyclin Drug Product Portfolio Table 88. Tide Pharma Recent Development Table 89. Actelion (J & J) Company Information Table 90. Actelion (J & J) Business Overview Table 91. Actelion (J & J) Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Actelion (J & J) Prostacyclin Drug Product Portfolio Table 93. Actelion (J & J) Recent Development Table 94. North America Prostacyclin Drug Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Prostacyclin Drug Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 97. North America Prostacyclin Drug Sales by Type (2027-2032) & (K Units) Table 98. North America Prostacyclin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 99. North America Prostacyclin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 100. North America Prostacyclin Drug Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Prostacyclin Drug Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 103. North America Prostacyclin Drug Sales by Application (2027-2032) & (K Units) Table 104. North America Prostacyclin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 105. North America Prostacyclin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 106. North America Prostacyclin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Prostacyclin Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. North America Prostacyclin Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. North America Prostacyclin Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 110. North America Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 111. North America Prostacyclin Drug Sales by Country (2027-2032) & (K Units) Table 112. North America Prostacyclin Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 113. North America Prostacyclin Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 114. United States Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 115. Canada Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 116. Europe Prostacyclin Drug Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Prostacyclin Drug Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 119. Europe Prostacyclin Drug Sales by Type (2027-2032) & (K Units) Table 120. Europe Prostacyclin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 121. Europe Prostacyclin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 122. Europe Prostacyclin Drug Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Prostacyclin Drug Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 125. Europe Prostacyclin Drug Sales by Application (2027-2032) & (K Units) Table 126. Europe Prostacyclin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 127. Europe Prostacyclin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 128. Europe Prostacyclin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Prostacyclin Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Prostacyclin Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Prostacyclin Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. Europe Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 133. Europe Prostacyclin Drug Sales by Country (2027-2032) & (K Units) Table 134. Europe Prostacyclin Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 135. Europe Prostacyclin Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 136. Germany Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 137. France Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 138. U.K. Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 139. Italy Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 141. China Prostacyclin Drug Revenue by Type (2021-2026) & (US$ Million) Table 142. China Prostacyclin Drug Revenue by Type (2027-2032) & (US$ Million) Table 143. China Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 144. China Prostacyclin Drug Sales by Type (2027-2032) & (K Units) Table 145. China Prostacyclin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 146. China Prostacyclin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 147. China Prostacyclin Drug Revenue by Application (2021-2026) & (US$ Million) Table 148. China Prostacyclin Drug Revenue by Application (2027-2032) & (US$ Million) Table 149. China Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 150. China Prostacyclin Drug Sales by Application (2027-2032) & (K Units) Table 151. China Prostacyclin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 152. China Prostacyclin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Asia Prostacyclin Drug Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia Prostacyclin Drug Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 156. Asia Prostacyclin Drug Sales by Type (2027-2032) & (K Units) Table 157. Asia Prostacyclin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 158. Asia Prostacyclin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 159. Asia Prostacyclin Drug Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia Prostacyclin Drug Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 162. Asia Prostacyclin Drug Sales by Application (2027-2032) & (K Units) Table 163. Asia Prostacyclin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 164. Asia Prostacyclin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Prostacyclin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Prostacyclin Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia Prostacyclin Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia Prostacyclin Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 169. Asia Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 170. Asia Prostacyclin Drug Sales by Country (2027-2032) & (K Units) Table 171. Asia Prostacyclin Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 172. Asia Prostacyclin Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 173. Japan Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 174. South Korea Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 175. India Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 176. Australia Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 177. China Taiwan Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 179. SAMEA Prostacyclin Drug Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA Prostacyclin Drug Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA Prostacyclin Drug Sales by Type (2021-2026) & (K Units) Table 182. SAMEA Prostacyclin Drug Sales by Type (2027-2032) & (K Units) Table 183. SAMEA Prostacyclin Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 184. SAMEA Prostacyclin Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 185. SAMEA Prostacyclin Drug Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA Prostacyclin Drug Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA Prostacyclin Drug Sales by Application (2021-2026) & (K Units) Table 188. SAMEA Prostacyclin Drug Sales by Application (2027-2032) & (K Units) Table 189. SAMEA Prostacyclin Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 190. SAMEA Prostacyclin Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 191. SAMEA Prostacyclin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA Prostacyclin Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA Prostacyclin Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA Prostacyclin Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 195. SAMEA Prostacyclin Drug Sales by Country (2021-2026) & (K Units) Table 196. SAMEA Prostacyclin Drug Sales by Country (2027-2032) & (K Units) Table 197. SAMEA Prostacyclin Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 198. SAMEA Prostacyclin Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 199. Brazil Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 200. Argentina Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 201. Chile Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 202. Colombia Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 203. Peru Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 205. Israel Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 206. UAE Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 207. Turkey Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 208. Iran Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 209. Egypt Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. Prostacyclin Drug Distributors List Table 213. Prostacyclin Drug Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. Prostacyclin Drug Image Figure 2. Global Prostacyclin Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostacyclin Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Beraprost Sodium Image Figure 5. Epoprostenol Sodium Image Figure 6. Treprostinil Image Figure 7. Iloprost Image Figure 8. Global Prostacyclin Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Prostacyclin Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. For Injection Image Figure 11. For Inhalation Image Figure 12. For Oral Image Figure 13. Global Prostacyclin Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Prostacyclin Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Prostacyclin Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Prostacyclin Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Prostacyclin Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Prostacyclin Drug Sales (2021-2032) & (K Units) Figure 19. Global Prostacyclin Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Prostacyclin Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Prostacyclin Drug Sales YoY (2021-2032) & (K Units) Figure 22. Europe Prostacyclin Drug Sales YoY (2021-2032) & (K Units) Figure 23. China Prostacyclin Drug Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Prostacyclin Drug Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Prostacyclin Drug Sales YoY (2021-2032) & (K Units) Figure 26. Global Prostacyclin Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Prostacyclin Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Prostacyclin Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Prostacyclin Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Prostacyclin Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Prostacyclin Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Prostacyclin Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Prostacyclin Drug Sales Market Share by Type (2021-2032) Figure 35. Global Prostacyclin Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Prostacyclin Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Prostacyclin Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Prostacyclin Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Prostacyclin Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Prostacyclin Drug Sales Market Share by Application (2021-2032) Figure 41. North America Prostacyclin Drug Revenue Share by Type (2021-2032) Figure 42. North America Prostacyclin Drug Sales Share by Type (2021-2032) Figure 43. North America Prostacyclin Drug Revenue Share by Application (2021-2032) Figure 44. North America Prostacyclin Drug Sales Share by Application (2021-2032) Figure 45. North America Prostacyclin Drug Revenue Share by Country (2021-2032) Figure 46. North America Prostacyclin Drug Sales Share by Country (2021-2032) Figure 47. Europe Prostacyclin Drug Revenue Share by Type (2021-2032) Figure 48. Europe Prostacyclin Drug Sales Share by Type (2021-2032) Figure 49. Europe Prostacyclin Drug Revenue Share by Application (2021-2032) Figure 50. Europe Prostacyclin Drug Sales Share by Application (2021-2032) Figure 51. Europe Prostacyclin Drug Revenue Share by Country (2021-2032) Figure 52. Europe Prostacyclin Drug Sales Share by Country (2021-2032) Figure 53. China Prostacyclin Drug Revenue Share by Type (2021-2032) Figure 54. China Prostacyclin Drug Sales Share by Type (2021-2032) Figure 55. China Prostacyclin Drug Revenue Share by Application (2021-2032) Figure 56. China Prostacyclin Drug Sales Share by Application (2021-2032) Figure 57. Asia Prostacyclin Drug Revenue Share by Type (2021-2032) Figure 58. Asia Prostacyclin Drug Sales Share by Type (2021-2032) Figure 59. Asia Prostacyclin Drug Revenue Share by Application (2021-2032) Figure 60. Asia Prostacyclin Drug Sales Share by Application (2021-2032) Figure 61. Asia Prostacyclin Drug Revenue Share by Country (2021-2032) Figure 62. Asia Prostacyclin Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Prostacyclin Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Prostacyclin Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Prostacyclin Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Prostacyclin Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Prostacyclin Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Prostacyclin Drug Sales Share by Country (2021-2032) Figure 69. Prostacyclin Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Prostacyclin Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Beraprost Sodium
  • Epoprostenol Sodium
  • Treprostinil
  • Iloprost
Applications
  • For Injection
  • For Inhalation
  • For Oral
Companies covered
  • Teva
  • GSK
  • Bayer AG
  • United Therapeutics
  • Toray
  • Tide Pharma
  • Actelion (J & J)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prostacyclin Drug Market by Type
  3. 1.2.1 Global Prostacyclin Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Beraprost Sodium
  5. 1.2.3 Epoprostenol Sodium
  6. 1.2.4 Treprostinil
  7. 1.2.5 Iloprost
  8. 1.3 Prostacyclin Drug Market by Application
  9. 1.3.1 Global Prostacyclin Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 For Injection
  11. 1.3.3 For Inhalation
  12. 1.3.4 For Oral
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Prostacyclin Drug Market Dynamics
  1. 2.1 Prostacyclin Drug Industry Trends
  2. 2.2 Prostacyclin Drug Industry Drivers
  3. 2.3 Prostacyclin Drug Industry Opportunities and Challenges
  4. 2.4 Prostacyclin Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prostacyclin Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prostacyclin Drug Revenue by Region
  3. 3.2.1 Global Prostacyclin Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prostacyclin Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Prostacyclin Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Prostacyclin Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prostacyclin Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prostacyclin Drug Sales by Region
  9. 3.4.1 Global Prostacyclin Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prostacyclin Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Prostacyclin Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Prostacyclin Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prostacyclin Drug Revenue by Manufacturers
  2. 4.1.1 Global Prostacyclin Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prostacyclin Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prostacyclin Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prostacyclin Drug Sales by Manufacturers
  6. 4.2.1 Global Prostacyclin Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prostacyclin Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prostacyclin Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prostacyclin Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prostacyclin Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prostacyclin Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prostacyclin Drug Manufacturers, Product Type & Application
  13. 4.7 Global Prostacyclin Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prostacyclin Drug Market CR5 and HHI
  16. 4.8.2 2025 Prostacyclin Drug Tier 1, Tier 2, and Tier 3
5 Prostacyclin Drug Market by Type
  1. 5.1 Global Prostacyclin Drug Revenue by Type
  2. 5.1.1 Global Prostacyclin Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prostacyclin Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prostacyclin Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prostacyclin Drug Sales by Type
  6. 5.2.1 Global Prostacyclin Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostacyclin Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Prostacyclin Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prostacyclin Drug Price by Type
6 Prostacyclin Drug Market by Application
  1. 6.1 Global Prostacyclin Drug Revenue by Application
  2. 6.1.1 Global Prostacyclin Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prostacyclin Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prostacyclin Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prostacyclin Drug Sales by Application
  6. 6.2.1 Global Prostacyclin Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prostacyclin Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Prostacyclin Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prostacyclin Drug Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Prostacyclin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Prostacyclin Drug Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Prostacyclin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Prostacyclin Drug Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Bayer AG
  14. 7.3.1 Bayer AG Company Information
  15. 7.3.2 Bayer AG Business Overview
  16. 7.3.3 Bayer AG Prostacyclin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer AG Prostacyclin Drug Product Portfolio
  18. 7.3.5 Bayer AG Recent Developments
  19. 7.4 United Therapeutics
  20. 7.4.1 United Therapeutics Company Information
  21. 7.4.2 United Therapeutics Business Overview
  22. 7.4.3 United Therapeutics Prostacyclin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 United Therapeutics Prostacyclin Drug Product Portfolio
  24. 7.4.5 United Therapeutics Recent Developments
  25. 7.5 Toray
  26. 7.5.1 Toray Company Information
  27. 7.5.2 Toray Business Overview
  28. 7.5.3 Toray Prostacyclin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Toray Prostacyclin Drug Product Portfolio
  30. 7.5.5 Toray Recent Developments
  31. 7.6 Tide Pharma
  32. 7.6.1 Tide Pharma Company Information
  33. 7.6.2 Tide Pharma Business Overview
  34. 7.6.3 Tide Pharma Prostacyclin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Tide Pharma Prostacyclin Drug Product Portfolio
  36. 7.6.5 Tide Pharma Recent Developments
  37. 7.7 Actelion (J & J)
  38. 7.7.1 Actelion (J & J) Company Information
  39. 7.7.2 Actelion (J & J) Business Overview
  40. 7.7.3 Actelion (J & J) Prostacyclin Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Actelion (J & J) Prostacyclin Drug Product Portfolio
  42. 7.7.5 Actelion (J & J) Recent Developments
8 North America
  1. 8.1 North America Prostacyclin Drug Market Size by Type
  2. 8.1.1 North America Prostacyclin Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Prostacyclin Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Prostacyclin Drug Price by Type (2021-2032)
  5. 8.2 North America Prostacyclin Drug Market Size by Application
  6. 8.2.1 North America Prostacyclin Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Prostacyclin Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Prostacyclin Drug Price by Application (2021-2032)
  9. 8.3 North America Prostacyclin Drug Market Size by Country
  10. 8.3.1 North America Prostacyclin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prostacyclin Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prostacyclin Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Prostacyclin Drug Market Size by Type
  2. 9.1.1 Europe Prostacyclin Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prostacyclin Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Prostacyclin Drug Price by Type (2021-2032)
  5. 9.2 Europe Prostacyclin Drug Market Size by Application
  6. 9.2.1 Europe Prostacyclin Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prostacyclin Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Prostacyclin Drug Price by Application (2021-2032)
  9. 9.3 Europe Prostacyclin Drug Market Size by Country
  10. 9.3.1 Europe Prostacyclin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prostacyclin Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prostacyclin Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Prostacyclin Drug Market Size by Type
  2. 10.1.1 China Prostacyclin Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Prostacyclin Drug Sales by Type (2021-2032)
  4. 10.1.3 China Prostacyclin Drug Price by Type (2021-2032)
  5. 10.2 China Prostacyclin Drug Market Size by Application
  6. 10.2.1 China Prostacyclin Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Prostacyclin Drug Sales by Application (2021-2032)
  8. 10.2.3 China Prostacyclin Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prostacyclin Drug Market Size by Type
  2. 11.1.1 Asia Prostacyclin Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prostacyclin Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Prostacyclin Drug Price by Type (2021-2032)
  5. 11.2 Asia Prostacyclin Drug Market Size by Application
  6. 11.2.1 Asia Prostacyclin Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prostacyclin Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Prostacyclin Drug Price by Application (2021-2032)
  9. 11.3 Asia Prostacyclin Drug Market Size by Country
  10. 11.3.1 Asia Prostacyclin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prostacyclin Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prostacyclin Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prostacyclin Drug Market Size by Type
  2. 12.1.1 SAMEA Prostacyclin Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prostacyclin Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prostacyclin Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Prostacyclin Drug Market Size by Application
  6. 12.2.1 SAMEA Prostacyclin Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prostacyclin Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prostacyclin Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Prostacyclin Drug Market Size by Country
  10. 12.3.1 SAMEA Prostacyclin Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prostacyclin Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prostacyclin Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prostacyclin Drug Value Chain Analysis
  2. 13.1.1 Prostacyclin Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prostacyclin Drug Production Mode & Process
  6. 13.2 Prostacyclin Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prostacyclin Drug Distributors
  9. 13.2.3 Prostacyclin Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst